-
Abbas AT, El-Kafrawy SA, Sohrab SS, Azhar EIA, 2019: IgY antibodies for the immunoprophylaxis and therapy of respiratory infections[J]. Hum Vaccin Immunother, 15, 264-275. doi: 10.1080/21645515.2018.1514224
-
Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S, 2009: The spike protein of SARS-CoV-a target for vaccine and therapeutic development[J]. Nat Rev Microbiol, 7, 226-236. doi: 10.1038/nrmicro2090
-
He Y, Li J, Du L, Yan X, Hu G, Zhou Y, Jiang S, 2006: Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine[J]. Vaccine, 24, 5498-5508. doi: 10.1016/j.vaccine.2006.04.054
-
He Y, Lu H, Siddiqui P, Zhou Y, Jiang S, 2005: Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies[J]. J Immunol, 174, 4908-4915. doi: 10.4049/jimmunol.174.8.4908
-
Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH 3rd, Kato T, Lee RE, Yount BL, Mascenik TM, 2020: SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract[J]. Cell, 182, 429-446.e414. doi: 10.1016/j.cell.2020.05.042
-
Lee WS, Wheatley AK, Kent SJ, DeKosky BJ, 2020: Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies[J]. Nat Microbiol, 5, 1185-1191. doi: 10.1038/s41564-020-00789-5
-
Pereira EPV, van Tilburg MF, Florean E, Guedes MIF, 2019: Egg yolk antibodies (IgY) and their applications in human and veterinary health: a review[J]. Int Immunopharmacol, 73, 293-303. doi: 10.1016/j.intimp.2019.05.015
-
Su S, Du L, Jiang S, 2020: Learning from the past: development of safe and effective COVID-19 vaccines[J]. Nat Rev Microbiol, , -. doi: 10.1038/s41579-020-00462-y:1-9
-
Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L, 2020: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion[J]. Cell Res, 30, 343-355. doi: 10.1038/s41422-020-0305-x
-
Zeng X, Tian G, Shi J, Deng G, Li C, Chen H, 2018: Vaccination of poultry successfully eliminated human infection with H7N9 virus in China[J]. Sci China Life Sci, 61, 1465-1473. doi: 10.1007/s11427-018-9420-1